Ongoing Impacts of COVID-19 Pandemic Constitute “Material Adverse Effect”Company Intends to Explore Other Strategic Collaborations with EOSTerminates Debt Commitment of […]
Rockville, MD, April 27, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]